← FDA DRUG APPROVALS

FDA ANDA · ANDA063063

CEPHALEXIN

Sponsor: APOTHECON

APPLICATION
ANDA063063
TYPE
ANDA
ORIGINAL APPROVAL
1989-09-29
LATEST ACTION
1996-07-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CEPHALEXINDiscontinued
CEPHALEXIN EQ 250MG BASE · CAPSULE · ORAL
CEPHALEXINDiscontinued
CEPHALEXIN EQ 500MG BASE · CAPSULE · ORAL

Approval history

1996-07-08Manufacturing (CMC) · Supplement 3AP
1996-07-08Labeling · Supplement 2AP
1995-02-08Labeling · Supplement 1AP
1989-09-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →